# A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants

> **NCT05367388** · PHASE1 · UNKNOWN · sponsor: **Apollomics Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** APL-101
- **DRUG:** PLB-1001

## Key facts

- **NCT ID:** NCT05367388
- **Lead sponsor:** Apollomics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-20
- **Primary completion:** 2022-11
- **Final completion:** 2022-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367388, "A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05367388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*